Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 1Multiple Endocrine Neoplasia Type 1 1Focal Cortical Dysplasia 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Everolimus 6Cannabidiol 6radiprodil 3ganaxolone 3Sirolimus 2Melatonin 2exemestane 1dactolisib 1Solutions 1Itraconazole 1Injections 1Carbamazepine 12-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Tuberous Sclerosis × Carbamazepine × Clear all
NCT06965881 2025-11-21

Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults

GRIN Therapeutics, Inc.

Phase 1 Terminated
30 enrolled

Focal Cortical Dysplasia, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡